AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus

AtriCure Reports Third Quarter 2015 Financial Results

October 27, 2015 4:01 PM EDT

Revenue of $31.4 million up 17.8% as reported, 20.6% constant currency U.S. sales of $24.7 million up 23.0% International sales of $6.7 million up 2.1% as reported, 13.2% constant currency

WEST CHESTER, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced third quarter 2015 financial results.

We are pleased with our performance in the third quarter and excited about our prospects for sustained growth, said Mike Carrel, President and Chief Executive... More